Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients

Vaccine

Volumn 29, Issue 34, 2011, Pages 5638-5644

  Cotte, L ^a,b   Voirin, N ^b,d   Richard, C ^a,j   Brochier, C ^a,i   Schlienger, I ^a,i   Lack, P ^a   Lina, B ^e,f,g,h   Vanhems, P ^c,d   Zoulim, F ^a,b,d  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITÉ DE LYON   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f Centre National de Réference Virus Influenza Région Sud   (France)

^g UNIVERSITÉ DE LYON   (France)

^h Laboratoire de Virologie   (France)

ⁱ CROIX ROUSSE HOSPITAL   (France)

^j CENTRE HOSPITALIER LE VINATIER   (France)

more..

Author keywords

A H1N1; HIV; Pandemic influenza; Vaccine coverage

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; BIOLOGICAL TRAIT; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; FRANCE; GENDER; HIGH RISK POPULATION; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGANIZATION; PANDEMIC; PREGNANCY; PRIORITY JOURNAL; RISK; RISK FACTOR; UNIVARIATE ANALYSIS; VACCINATION; VIROTHERAPY;

AGE FACTORS; DISEASE OUTBREAKS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MASS VACCINATION; PANDEMICS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PREGNANCY; SEXUAL BEHAVIOR;

EID: 79960563697     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.013     Document Type: Article

References (28)

1. Vaux S., Brouard C., Fuhrman C., Turbelin C., Cohen J.M., Valette M., et al. Dynamique et impact de l'épidémie A(H1N1) 2009 en France métropolitaine, 2009-2010. Bull Epidémiol Hebdomadaire 2010, 24-25-26:259-263. [in French].
2. World Health Organization. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General Dr. Margaret Chan. Geneva: WHO; June 11, 2009. Available from: [accessed 07.11.10]. http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html.
3. Ministère de la santé et des sports. Lancement de la campagne vaccinale contre la grippe A(H1N1) dans les centres de vaccination [Launch of A(H1N1) influenza vaccination campaign in vaccination centres] [in French]. Available from: [accessed 01.11.10]. http://www.sante-jeunesse-sports.gouv.fr/IMG/pdf/Lancement_de_la_campagne_vaccinale_contre_la_grippe_A_H1N1_dans_les_centres_de_vaccination.pdf.
4. Bone A., Guthmann J.P., Nicolau J., Lévy-Bruhl D. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 2010, 28:8157-8161.
5. Kunizaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9:493-504.
6. Neuzil K.M., Reed G.W., Mitchel E.F., Griffin M.R. Influenza associated morbidity and mortality in young and middle-aged women. JAMA 1999, 281:901-907.
7. Lin J.C., Nichol K.L. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001, 161:441-446.
8. Archer B., Cohen C., Naidoo D., Thomas J., Makunga C., Blumberg L., et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill 2009, 14. pii: 19369.
9. Ormsby C.E., de la Rosa-Zamboni D., Vázquez-Pérez J., Ablanedo-Terrazas Y., Vega-Barrientos R., Gómez-Palacio M., et al. Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. AIDS 2011, 25:435-439.
10. Haut Conseil de la Santé Publique. Avis: Actualisation de l'avis relatif aux recommandations sur l'utilisation des vaccins pandémiques dirigés contre le virus grippal A(H1N1)v [Actualisation of recommendation advise for the use of pandemic vaccines against A(H1N1)v influenza virus]; 28 octobre 2009 [in French]. Available from: [accessed 07.11.10]. http://www.hcsp.fr/docspdf/avisrapports/hcspa20091028_H1N1.pdf.
11. Ministère de la santé et des sports. Vaccination contre la grippe A(H1N1) 2009 des personnes vivant avec le VIH (PVVIH) [A(H1N1)2009 pandemic influenza vaccination of HIV-infected patients] [in French]. Available from: [accessed 07.11.10]. http://www.sante-sports.gouv.fr/IMG/pdf/20091105_vaccination_PVVIH.pdf.
12. Phillips A.N., Grabar S., Tassie J.M., Costagliola D., Lundgren J.D., Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS 1999, 13:2075-2082.
13. Suivi de l'adulte infecté par le VIH. In: Prise en charge médicale des personnes infectées par le VIH, Rapport 2008 sous la direction du Pr. Patrick Yeni, Recommandations du groupe d'experts. Paris, France: La Documentation Française; 2008. p. 61-97.
14. Institut National de Veille Sanitaire Calendrier des vaccinations et recommandations vaccinales 2009 selon l'avis du Haut Conseil de la Santé Publique. Bull Epidémiol Hebdomadaire 2009, 16-17:147-162. [in French].
15. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
16. Vaillant L., La Ruche G., Tarantola A., Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 2009, 14. pii: 19309.
17. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
18. Morgan O.W., Bramley A., Fowlkes A., Freedman D.S., Taylor T.H., Gargiullo P., et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010, 5:e9694.
19. Schwarzinger M., Flicoteaux R., Cortarenoda S., Obadia Y., Moatti J.P. Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?. PLoS One 2010, 5:e10199.
20. Raude J., Caille-Brillet A.L., Setbon M. The 2009 pandemic H1N1 influenza vaccination France: who accepted to receive the vaccine and why?. PLoS Curr 2010, 2:RRN1188.
21. Vaux S., Van Cauteren D., Guthmann J.P., Le Strat Y., Vaillant V., de Valk H., et al. Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 2011, 11:30.
22. Printza N., Farmaki E., Bosdou J., Gkogka C., Papachristou F. Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions. Hum Vaccin 2010, 6:819-822.
23. Nougairède A., Lagier J.C., Ninove L., Sartor C., Badiaga S., Botelho E., et al. Likely correlation between sources of information and acceptability of A/H1N1 swine-origin influenza virus vaccine in Marseille, France. PLoS One 2010, 5:e11292.
24. Blank P.R., Schwenkglenks M., Szucs T.D. Disparities in influenza vaccination coverages by target group in five European countries: trends over seven consecutive seasons. Infection 2009, 37:390-400.
25. Tuppin P., Samson S., Weill A., Ricordeau P., Allemand H. Taux de couverture vaccinale contre la grippe en France en 2007-2008: apport des données de remboursement du régime général. Med Mal Infect 2009, 39:780-788. [in French].
26. Gallagher K.M., Juhasz M., Harris N.S., Teshale E.H. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007, 196:339-346.
27. Barrière J., Vanjak D., Kriegel I., Otto J., Peyrade F., Estève M., et al. Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers. Vaccine 2010, 28:7030-7034.
28. Schwarzinger M., Verger P., Guerville M.A., Aubry C., Rolland S., Obadia Y., et al. Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?. Vaccine 2010, 28:2743-2748.